FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> cancer vaccine   breast cancer   TapImmune
Syndicate content

Mayo Clinic News

Most Popular Mayo Clinic Story

TapImmune, Mayo Clinic announce Ph1 breast cancer vaccine trial

Seattle-based TapImmune will sponsor a Mayo Clinic Phase I study of a therapeutic breast cancer vaccine, which has received FDA IND approval. Trial recruitment, which will focus on HER-2/neu positive Read more...

Mayo Clinic Press Releases

  • Cardio3 BioSciences Establishes US Subsidiary in Rochester, MN
  • SK biopharmaceuticals Enters into a Collaboration Agreement to Study Lou Gehrig’s Disease
  • Mayo Clinic teams with glowing cats against AIDS, other diseases
  • Mayo Clinic finds social media valuable tool to recruit study participants for rare diseases
  • Quanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in Crohn's Disease

Latest Headlines